Abstract
About this talk
In the recent years with ever-growing commercialization in the field of medicinal plants and herbal medicines, there has been an instant demand for quality control of the drugs used in this system. For this standardization is usually recommended as the solution to the problem. The challenges are innumerable and enormous, making the global herbal market unsafe. This talk seeks to enlighten physicians, pharmacists, consumers and stakeholders in herbal medicine on the need to establish quality parameters for collection, handling, processing and production of herbal medicine as well; as employ such parameters in ensuring the safety of the global herbal market. The processes of good quality assurance and standardization of medicinal plants and and finished herbal products will also be discussed.
In the present study an attempt has been made to study the medicinal plants in general from selection of medicinal plants; Good Agricultural Practices (GAP); Good Cultivation Practices (GCP); Good Field Collection Practices (GFCP); Technical Planning; population density; Geographical distribution; Topographical maps; Collecting techniques & proceedures; Source and Period of Collection; Identification; Storage; Chemical Standardisation Assay; Current Good Manufacturing Practice (C GMP); Pre clinical studies to Clinical Approach; Good Marketing Practice (GMP), with special reference to maintain Standardisation at each and every stage and subsequent production of quality raw plant materials/products.
Different stages, i.e, Quality control studies of raw plant materials, Controled studies of Method of Processing of medicinal plants, Quality control studies of the finished product, Standardization proceedures at each stage from birth of the plants up to its clinical application & marketing have been described. Fingerprinting and adulteration of pharmaceuticals will be dealt in detail.
Speaker
About the speaker
